Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papillomaviridae”

1,252 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,252 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05797246
What this trial is testing

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Who this might be right for
Respiratory Tract DiseasesNeoplasmsNeoplasms by Histologic Type+12 more
National Cancer Institute (NCI) 21
Not applicableUnknownNCT00918710
What this trial is testing

Human Papillomavirus and Oropharynx Carcinoma

Who this might be right for
Oropharyngeal Neoplasms
Assistance Publique - Hôpitaux de Paris 362
Testing effectiveness (Phase 2)UnknownNCT02593968
What this trial is testing

Yallaferon in Chinese Population

Who this might be right for
HPV Infection
Lee's Pharmaceutical Limited 100
Large-scale testing (Phase 3)WithdrawnNCT02100618
What this trial is testing

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Not applicableStudy completedNCT04401670
What this trial is testing

Cervical Cancer Screening in Cameroon

Who this might be right for
Cervical CancerHIV/AIDS
Albert Einstein College of Medicine 873
Large-scale testing (Phase 3)Study completedNCT03493542
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Who this might be right for
Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
Merck Sharp & Dohme LLC 766
Not applicableStudy completedNCT04587050
What this trial is testing

Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV

Who this might be right for
HIV InfectionsHuman Papillomavirus InfectionCervical Cancer
Imperial College London 57
Early research (Phase 1)Study completedNCT04084951
What this trial is testing

Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 30
Large-scale testing (Phase 3)WithdrawnNCT00733122
What this trial is testing

Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC
Not applicableUnknownNCT00892866
What this trial is testing

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

Who this might be right for
Atypical Endometrial HyperplasiaHuman Papillomavirus InfectionStage 0 Cervical Cancer AJCC v7
GOG Foundation 877
Large-scale testing (Phase 3)Study completedNCT01047345
What this trial is testing

V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

Who this might be right for
Cervical CancersVulvar CancersVaginal Cancers+1 more
Merck Sharp & Dohme LLC 924
Testing effectiveness (Phase 2)Study completedNCT00359619
What this trial is testing

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 383
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06210854
What this trial is testing

Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+

Who this might be right for
HPV Infection
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Not applicableStudy completedNCT01077856
What this trial is testing

GARDASIL™ Vaccine Impact in Population Study (V501-033)

Who this might be right for
Human Papillomavirus Infections
Merck Sharp & Dohme LLC 54,516
Large-scale testing (Phase 3)Active Not RecruitingNCT04537156
What this trial is testing

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerCondylomata Acuminata
Xiamen University 9,327
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Not applicableUnknownNCT01897129
What this trial is testing

Human Papillomavirus and Pregnancy

Who this might be right for
HPV-infection in Pregnant Women
Ulla Bonde van Zwol 546
Not applicableStudy completedNCT02714127
What this trial is testing

Standard Operating Procedures for Cervical (Pre)Cancer Biomarker Detection in First-void Urine (BM-SOP Study)

Who this might be right for
Cervical Cancer
Universiteit Antwerpen 128
Not applicableLooking for participantsNCT06642324
What this trial is testing

Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas

Who this might be right for
Head Neck CancerOropharyngeal Neoplasms
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 550
Not applicableUnknownNCT06245486
What this trial is testing

Probiotc Lactobacillus Crispatus-M247 (Crispact®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) Viruses

Who this might be right for
Human Papillomavirus Infection
Liaquat University of Medical & Health Sciences 150
Load More Results